Sophie Paczesny Pediatric Blood and Marrow Transplant Program University of Michigan Biography Publications Institution JoVE Articles Sophie Paczesny has not added a biography. If you are Sophie Paczesny and would like to personalize this page please email our Author Liaison for assistance. Publications TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2012 | Pubmed ID: 22469883 Acute Graft-versus-host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: a Blood and Marrow Transplant Clinical Trials Network Study Blood. Apr, 2012 | Pubmed ID: 22383800 Plasma Biomarkers of Lower Gastrointestinal and Liver Acute GVHD Blood. Mar, 2012 | Pubmed ID: 22286196 Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-host Disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2012 | Pubmed ID: 22226094 Role of Cytokines in the Pathophysiology of Acute Graft-versus-host Disease (GVHD): Are Serum/plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)? Current Stem Cell Research & Therapy. May, 2012 | Pubmed ID: 22023620 Regenerating Islet-derived 3-alpha is a Biomarker of Gastrointestinal Graft-versus-host Disease Blood. Dec, 2011 | Pubmed ID: 21979939 Clofarabine and Busulfan Conditioning Facilitates Engraftment and Provides Significant Antitumor Activity in Nonremission Hematologic Malignancies Blood. Oct, 2011 | Pubmed ID: 21841163 Translational Research Efforts in Biomarkers and Biology of Early Transplant-related Complications Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2011 | Pubmed ID: 21195297 Immunotherapy Through T-cell Receptor Gene Transfer Induces Severe Graft-versus-host Disease Immunotherapy. Nov, 2010 | Pubmed ID: 21091111 Novel Proteins Associated with Risk for Coronary Heart Disease or Stroke Among Postmenopausal Women Identified by In-depth Plasma Proteome Profiling Genome Medicine. 2010 | Pubmed ID: 20667078 Elafin is a Biomarker of Graft-versus-host Disease of the Skin Science Translational Medicine. Jan, 2010 | Pubmed ID: 20371463 Frequency of CD4(+)CD25(hi)FOXP3(+) Regulatory T Cells Has Diagnostic and Prognostic Value As a Biomarker for Acute Graft-versus-host-disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2010 | Pubmed ID: 20302964 Postmenopausal Estrogen and Progestin Effects on the Serum Proteome Genome Medicine. 2009 | Pubmed ID: 20034393 Acute Graft-versus-host Disease: New Treatment Strategies Current Opinion in Hematology. Nov, 2009 | Pubmed ID: 19812490 Mesenchymal Stem Cells for Treatment and Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation Current Stem Cell Research & Therapy. Dec, 2009 | Pubmed ID: 19500066 Application of Serum Proteomics to the Women's Health Initiative Conjugated Equine Estrogens Trial Reveals a Multitude of Effects Relevant to Clinical Findings Genome Medicine. 2009 | Pubmed ID: 19402886 Plasma Biomarkers in Graft-versus-host Disease: a New Era? Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2009 | Pubmed ID: 19147075 A Biomarker Panel for Acute Graft-versus-host Disease Blood. Jan, 2009 | Pubmed ID: 18832652 Plasma Elevations of Tumor Necrosis Factor-receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-host Disease Severity and Overall Survival in Pediatric Patients Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2008 | Pubmed ID: 18541194 Change in Plasma Tumor Necrosis Factor Receptor 1 Levels in the First Week After Myeloablative Allogeneic Transplantation Correlates with Severity and Incidence of GVHD and Survival Blood. Aug, 2008 | Pubmed ID: 18502834 Plasma Proteome Profiling of a Mouse Model of Breast Cancer Identifies a Set of Up-regulated Proteins in Common with Human Breast Cancer Cells Journal of Proteome Research. Apr, 2008 | Pubmed ID: 18311905 Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells Through Activation of the Notch Pathway Journal of Immunology (Baltimore, Md. : 1950). Feb, 2008 | Pubmed ID: 18209056 Etanercept Plus Methylprednisolone As Initial Therapy for Acute Graft-versus-host Disease Blood. Feb, 2008 | Pubmed ID: 18042798 Efficient Generation of CD34+ Progenitor-derived Dendritic Cells from G-CSF-mobilized Peripheral Mononuclear Cells Does Not Require Hematopoietic Stem Cell Enrichment Journal of Leukocyte Biology. Apr, 2007 | Pubmed ID: 17229904 Long-term Outcomes in Patients with Metastatic Melanoma Vaccinated with Melanoma Peptide-pulsed CD34(+) Progenitor-derived Dendritic Cells Cancer Immunology, Immunotherapy : CII. Oct, 2006 | Pubmed ID: 16331519 Spontaneous Proliferation and Type 2 Cytokine Secretion by CD4+T Cells in Patients with Metastatic Melanoma Vaccinated with Antigen-pulsed Dendritic Cells Journal of Clinical Immunology. May, 2005 | Pubmed ID: 15981095 Immunotherapy Via Dendritic Cells Advances in Experimental Medicine and Biology. 2005 | Pubmed ID: 15932026 Boosting Vaccinations with Peptide-pulsed CD34+ Progenitor-derived Dendritic Cells Can Expand Long-lived Melanoma Peptide-specific CD8+ T Cells in Patients with Metastatic Melanoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Mar-Apr, 2005 | Pubmed ID: 15725960 Measuring Melanoma-specific Cytotoxic T Lymphocytes Elicited by Dendritic Cell Vaccines with a Tumor Inhibition Assay in Vitro Journal of Immunotherapy (Hagerstown, Md. : 1997). Mar-Apr, 2005 | Pubmed ID: 15725959 Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells The Journal of Experimental Medicine. Jun, 2004 | Pubmed ID: 15173207 Dendritic Cells As Vectors for Immunotherapy of Cancer Seminars in Cancer Biology. Dec, 2003 | Pubmed ID: 15001163 Single Injection of CD34+ Progenitor-derived Dendritic Cell Vaccine Can Lead to Induction of T-cell Immunity in Patients with Stage IV Melanoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep-Oct, 2003 | Pubmed ID: 12973032 Dendritic Cells: Controllers of the Immune System and a New Promise for Immunotherapy Annals of the New York Academy of Sciences. Apr, 2003 | Pubmed ID: 12727638 Akut Graft-Versus-Host Hastalığı Biyomarkörler onaylanması için Yüksek Verimli Sıralı ELISA Bryan Fiema*1, Andrew C. Harris*1, Aurelie Gomez1, Praechompoo Pongtornpipat1, Kelly Lamiman1, Mark T. Vander Lugt1, Sophie Paczesny1 1Pediatric Blood and Marrow Transplant Program, University of Michigan JoVE 4247 Medicine
Akut Graft-Versus-Host Hastalığı Biyomarkörler onaylanması için Yüksek Verimli Sıralı ELISA Bryan Fiema*1, Andrew C. Harris*1, Aurelie Gomez1, Praechompoo Pongtornpipat1, Kelly Lamiman1, Mark T. Vander Lugt1, Sophie Paczesny1 1Pediatric Blood and Marrow Transplant Program, University of Michigan JoVE 4247 Medicine